The EIS & SEIS Annual Report 2025 has been released as part of the annual Tax Efficient Investment Report series by IFA Magazine and GBI Magazine. This highly regarded report provides a comprehensive analysis of the Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS), which are central to the UK’s thriving innovation ecosystem.
Expert Insights and Industry Analysis
Researched and written by leading Compliance Consultant Tony Catt, the report is a go-to resource for investors, financial advisers, and stakeholders in the tax-efficient investment space. It examines the benefits and risks of these schemes while considering their role in a diversified investment portfolio. With a focus on recent trends and the implications of Consumer Duty regulations, the report delivers valuable insights for both experienced and new investors.
Parkwalk: Supporting UK Innovation
Parkwalk is proud to feature in this edition alongside other leading managers in this space. Our inclusion highlights our expertise in supporting high-growth businesses and university spinouts, which are key beneficiaries of EIS and SEIS. These schemes offer significant benefits for investors, including tax reliefs and the opportunity to back innovative businesses driving progress in sectors such as science, technology, and sustainability.
Why EIS and SEIS Matter
The EIS & SEIS Annual Report also provides a comparison of the two schemes, detailing their unique advantages and the value they bring to clients and individual investors. It serves as an essential guide for understanding how these government-backed initiatives continue to support UK innovation and foster economic growth.
To explore these schemes in detail and learn how they are shaping the future of UK business, download the full report here: EIS & SEIS Annual Report 2025.
Parkwalk’s EIS Funds
Our current open funds include the Knowledge Intensive EIS Fund IV, the Opportunities EIS Fund and the University of Cambridge Enterprise Fund X. Please email [email protected] or visit our funds page to find out more.
Parkwalk Advisors Limited (Parkwalk) is authorised and regulated by the Financial Conduct Authority: FRN 502237. Investments referred to in this news article are not suitable for all investors. Capital is at risk and investors may not get back the full amount invested. Any investment in a Parkwalk product must only be made on the basis of the terms of the full Information Memorandum. Tax treatment depends on the individual circumstances of each investor. Parkwalk is not able to provide advice as to the suitability of investing in any product. Past performance is not a reliable indicator of future results.This financial promotion was approved in January 2025.
